Pharmacokinetic basis for dosing high‐dose methotrexate in infants and young children with malignant brain tumours

AIMS: No population pharmacokinetic studies of high‐dose methotrexate (HDMTX) have been conducted in infants with brain tumours, which are a vulnerable population. The aim of this study was to evaluate HDMTX disposition in these children to provide a rational basis for MTX dosing. METHODS: Patients...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Br J Clin Pharmacol
Glavni autori: Panetta, John C., Roberts, Jessica K., Huang, Jie, Lin, Tong, Daryani, Vinay M., Harstead, K. Elaine, Patel, Yogesh T., Onar‐Thomas, Arzu, Campagne, Olivia, Ward, Deborah A., Broniscer, Alberto, Robinson, Giles, Gajjar, Amar, Stewart, Clinton F.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2020
Teme:
Original Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7015755/
https://ncbi.nlm.nih.gov/pubmed/31657864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.14160
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items